ARAY stock down after Q4 earnings miss estimates, with product sales hit by tariffs and regional demand softness.
Accuray Incorporated (NASDAQ:ARAY ) Q4 2025 Earnings Conference Call August 13, 2025 4:30 PM ET Company Participants Ali Pervaiz - Senior VP & CFO Suzanne Winter - President, CEO & Director Conference

Accuray (ARAY) Reports Break-Even Earnings for Q4

06:26pm, Wednesday, 13'th Aug 2025
Accuray (ARAY) reported break-even quarterly earnings per share versus the Zacks Consensus Estimate of $0.03. This compares to earnings of $0.03 per share a year ago.
Strong Service Growth; Debt Refinancing Complete; Company Issues FY26 Guidance MADISON, Wis., Aug. 13, 2025 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported financial results for th
MADISON, Wis. , July 30, 2025 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report financial results for the fourth quarter of fiscal year 2025, ended June 30, 2025, during a conference cal
ARAY rides strong global demand and CyberKnife momentum, but order declines and backlog pressure temper the outlook.
ARAY continues to witness strength in its flagship, CyberKnife system, along with robust global performance.
MADISON, Wis. , June 6, 2025 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today announced that, after an extensive review over the last several months, including the evaluation of numerous pot
Accuray (ARAY) reported earnings 30 days ago. What's next for the stock?
MADISON, Wis. , May 29, 2025 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today its participation in the Jefferies Global Healthcare Conference 2025.
ARAY continues to witness strength in its flagship, CyberKnife system, along with robust global performance.
More than 40 Clinical Studies Using Accuray Technology Presented at ESTRO 2025; Company Highlights Innovation and Educational Symposia MADISON, Wis. , May 7, 2025 /PRNewswire/ -- Accuray Incorporated
Medical Team's Use of Accuray CyberComm™ Reduced Commissioning Time by Approximately 50 Percent*, Enabling Them to Initiate Patient Treatments Sooner MADISON, Wis. , May 5, 2025 /PRNewswire/ -- Accu
Accuray has consistently struggled with execution, and now tariffs threaten to significantly impact the company's business in China - it's most promising growth driver. Recent Q3 results showed revenu
Accuray reports solid fiscal third-quarter results, witnessing growth in Product & Services revenues and reduced operating expenses.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE